Log on / register
Feedback | Support | My details
Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria.
Stepniewska K, White NJ
Malar J 2006, 5:127
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.
Nahum A, Erhart A, Gazard D, Agbowai C, Van Overmeir C, van Loen H, Menten J, Akogbeto M, Coosemans M, Massougbodji A, D'Alessandro U
Malar J 2007, 6:170
 [PubMed Central] [PubMed] [Related articles]
2.
Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières.
Guthmann JP, Checchi F, van den Broek I, Balkan S, van Herp M, Comte E, Bernal O, Kindermans JM, Venis S, Legros D, Guerin PJ
PLoS Med 2008 Aug 5, 5:e169
 [PubMed Central] [PubMed] [Related articles]
3.
*** Unable to retrieve article 18684011 ***

 [PubMed Central] [PubMed] [Related articles]
4.
Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria.
Crompton PD, Traore B, Kayentao K, Doumbo S, Ongoiba A, Diakite SA, Krause MA, Doumtabe D, Kone Y, Weiss G, Huang CY, Doumbia S, Guindo A, Fairhurst RM, Miller LH, Pierce SK, Doumbo OK
J Infect Dis 2008 Nov 1, 198:1265-75
 [PubMed Central] [PubMed] [Related articles]
5.
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.
Borrmann S, Peto T, Snow RW, Gutteridge W, White NJ
PLoS Med 2008 Nov 18, 5:e227
 [PubMed Central] [PubMed] [Related articles]
6.
*** Unable to retrieve article 19018658 ***

 [PubMed Central] [PubMed] [Related articles]
7.
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581.
Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, Mosha JF, Joho A, Mandia V, Mrema H, Mapunda E, Savael Z, Lemnge M, Mosha FW, Greenwood B, Roper C, Chandramohan D
PLoS One 2009, 4:e4569
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 6 articles in BioMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.